Frequently bought together:
Description
BRAF inhibitor | HY-10247
BRAF inhibitor is a B-Raf inhibitor extracted from patent WO/2011103196 A1, Compound P-0850.
IC50 & Target :
B-Raf
Molecular weight:
456.47
Formula:
C22H18F2N4O3S
SMILES:
CC(C)S(=O)(NC1=CC=C(C(C(C2=CNC3=NC=C(C=C32)C4=CC=CN=C4)=O)=C1F)F)=O
Storage:
Related Products
AKT Kinase Inhibitor | HY-10249A
Gentaur
AKT Kinase Inhibitor | HY-10249A
AKT Kinase Inhibitor is an Akt kinase inhibitor with anti-tumor activity[1].
IC50 & Target :
Akt
In Vitro:
The effect of selective inhibition of Akt in...
Adezmapimod | HY-10256
Gentaur
Adezmapimod | HY-10256
Adezmapimod (SB 203580) is a selective and ATP-competitive p38 MAPK inhibitor with IC50s of 50 nM and 500 nM for SAPK2a/p38 and SAPK2b/p38β2, respectively. Adezmapimod inhibits...
Bortezomib | HY-10227
Gentaur
Bortezomib | HY-10227
Bortezomib (PS-341) is a reversible and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki=0.6 nM) by targeting a threonine residue. Bortezomib disrupts...
Ixabepilone | HY-10222
Gentaur
Ixabepilone | HY-10222
Ixabepilone (BMS-247550) is an orally bioavailable microtubule inhibitor, which binds to tubulin and promotes tubulin polymerization and microtubule stabilization, thereby...
Luminespib | HY-10215
Gentaur
Luminespib | HY-10215
Luminespib (VER-52296) is a potent HSP90 inhibitor with IC50s of 7.8 and 21 nM for HSP90α and HSP90β, respectively.
IC50 & Target: